Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.3M Sell
983
-189
-16% -$259K 0.5% 42
2025
Q4
$1.25M Sell
1,172
-4
-0.3% -$4.17K 0.51% 43
2025
Q3
$1.14M Buy
1,176
+30
+3% +$23.6K 0.49% 46
2025
Q2
$918K Buy
1,146
+130
+13% +$93.3K 0.42% 53
2025
Q1
$673K Buy
1,016
+202
+25% +$147K 0.33% 67
2024
Q4
$564K Buy
814
+328
+67% +$236K 0.28% 71
2024
Q3
$405K Buy
486
+54
+13% +$48.3K 0.19% 89
2024
Q2
$442K Buy
432
+98
+29% +$94.2K 0.23% 80
2024
Q1
$324K Buy
+334
New +$296K 0.17% 98

Other funds holding ASML

MBA Advisors's ASML Position: Q1 2026 in Review

MBA Advisors reduced its ASML (ASML) stake by 16% in Q1 2026, selling an estimated $259K and leaving 983 shares worth $1.3M. The position accounts for 0.5% of the portfolio, ranked #42.

MBA Advisors first reported a position in ASML in Q1 2024 and has held it in 9 quarters since. 2,188 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

  • MBA Advisors held 983 shares of ASML worth $1.3M as of Q1 2026.
  • MBA Advisors sold 189 ASML shares in Q1 2026, an estimated $259K.
  • ASML made up 0.5% of MBA Advisors's portfolio in Q1 2026, its #42 holding.
  • MBA Advisors first reported a position in ASML in Q1 2024 and has held it in 9 quarters since.
  • 2,188 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on MBA Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.